Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To evaluate the safety and effectiveness of cell therapy using Precision Cells to treat Advanced Gastric Cancer. Eligibility: Individuals greater than or equal to 18 years of age and less than or equal to 65 years of age who have been diagnosed with Advanced Gastric Cancer.
Epistemonikos ID: d1793288dd48f40636f92b0716770f516cfb3b76
First added on: May 17, 2024